INTRODUCTION
============

Exercise has been widely recommended as an important tool to improve muscle strength, muscle cross-sectional area and general health parameters. Different exercise protocols, such as resistance training (RT), jumping, swimming, wheel running and treadmill running in rodents results in positive adaptations in skeletal muscle ([@b1-ijes_10_7_1051],[@b6-ijes_10_7_1051],[@b15-ijes_10_7_1051],[@b16-ijes_10_7_1051]). Although the phenotypic alterations induced by exercise training have been widely described, the molecular mechanisms, mainly proteomics muscle profile, responsible for skeletal muscle adaptations are not fully understood.

Molecular networks of exercise-induced changes in skeletal muscle have been characterized by proteomics, which is a technique based on mass spectrometry ([@b12-ijes_10_7_1051],[@b13-ijes_10_7_1051]). One advantage of this method is the ability to quantify a large number of proteins at the same time, whereas immunoblotting can only be utilized to analyze individual target proteins previously identified (or speculated) to be of importance to a particular physiological adaptation ([@b25-ijes_10_7_1051]).

In order to progressively promote training adaptations during RT, various factors can be manipulated including a) the number of exercises, b) repetitions performed per set, or c) sets per exercise. Moreover, the increase of RT volume results in positive neural adjustments, increased muscle mass, and improved metabolic and endocrine responses ([@b17-ijes_10_7_1051]). However, excessive training, including an increased volume, may result in lipid peroxidation in skeletal muscle and underperformance related to overtraining syndrome ([@b4-ijes_10_7_1051]).

Furthermore, it has been demonstrated that four weeks of endurance or resistance training differently modified individual muscle protein expression, and that these responses may be associated with specific muscular adaptations to RT in humans ([@b20-ijes_10_7_1051]). Thus, the investigation of different RT volume on muscle proteomics may contribute to new insights into training adaptations. The aim of the current investigation was to determine the effects of eight weeks of low volume RT (4 sets of climbing a vertical ladder) and high volume (8 sets) on gastrocnemius muscle proteome and muscle cross sectional area (CSA) of rats, and compare with a control group. The initial hypothesis was that a higher RT volume will increase muscle CSA to a greater extent without negative changes in muscle proteomics.

METHODS
=======

Animals
-------

Fourteen male *Wistar* rats aged 5 months were divided into 3 groups: resistance training with 4 sets (RT4, n=5), resistance training with 8 sets (RT8, n=5) and control group (CON, n = 4). All animals came from the Central vivarium of the *Faculdade de Educação Física da Universidade Católica de Brasília*. The animals were housed in polypropylene cages (4 animals per cage) at a temperature of 23 ± 2 °C with 12:12h dark:light cycle and food and water provided ad libitum. All procedures were approved by the Institutional Animal Care and Uses Local Committee (CEUA UCB) and were in accordance with international ethical standards.

Protocol
--------

The RT protocol was adapted from Hornberger and Farrar ([@b6-ijes_10_7_1051]), and procedures are described elsewhere ([@b16-ijes_10_7_1051],[@b17-ijes_10_7_1051],[@b22-ijes_10_7_1051]). Briefly, the duration of resistance training lasted 8 weeks and was performed 3 times per week. A initial adaptation period was provided which consisted of the animals climbing a vertical ladder (1.1 m, 0.18 m, 2-cm grid, 80 ° incline, 8--12 movements per climb) with a load secured to their tails. When necessary, a stimulus was applied to the animal's tail to initiate movement. At the top of the ladder, the animals rested for 120 s and the procedure was repeated until the animal voluntarily climbed the ladder 3 consecutive times without a stimulus applied.

Training sessions began 3 days following the familiarization protocol, and involved 4 (RT4) or 8 (RT8) ladder climbs with progressively heavier loads. The initial climb was equivalent to 75 % of the body mass. Subsequently, an additional 30 g weight was added until a load was reached which the animal could not climb the entire ladder length. Failure was determined when the animal could not complete the ladder climb after 3 consecutive stimuli to the tail. The greatest load successfully carried the entire ladder length was deemed the maximal carrying capacity for that training session and used for calculate the training load for the next session. Training sessions for the RT4 group consisted of a total of four ladder climbs in increasing intensity (50%, 75%, 90%, and 100% of maximal carrying capacity). The RT8 group performed two climbs at each intensity for a total of 8 climbs. Total volume training (total ladder climbs completed × load) was adapted from Tibana, et al.([@b7-ijes_10_7_1051]) according to the experimental model.

Animals were anesthetized using an intraperitoneal injection with a solution of xylazine (12 mg/Kg of body weight) five days after the last training session and further euthanized using ketamine (95 mg/Kg of body weight) and weighed. Five days after the last RT session, the central part of the gastrocnemius muscle from all experimental groups (4 animals for CON; 5 animals for RT4 and 5 animals for RT8) were dissected and immediately washed in saline solution. Samples were weighed, frozen in liquid nitrogen and conserved at −80°C. Subsequently, samples were fixed in the metallic supports of a cryostat. (Micron HE 505, Jena, Germany) at −20ºC with small stickers (OCT -- Tissue Tek Compound) and oriented with slices of 5 m that allowed a transversal observation of muscle fibers adjusted in glass laminas. Six histological laminas of each animal were than stained with hematoxylin-eosin (HE) to evaluate cross sectional area (CSA).

Images from five different muscle regions were obtained by a capture system and computerized image analysis with a digital camera Axioplan (Carl Zeiss, Oberkochen, Germany) at 10X amplification coupled to a binocular microscope (Olympus® BX51 ). The CSA of 100 fibers was randomly chosen from each image and measured by using the software Image J. The normalization of these values was calculated by the mean CSA divided by the animal body mass (CSA/body mass). All images were analyzed by the same researcher in a blinded design, in which the analyzer was not aware of the experimental group.

The gastrocnemius was carefully removed, weighed and partitioned into two at the middle of the belly: with the proximal fragment used for the CSA analysis and the distal segment for proteomic assessment. With regard to CSA evaluation, the muscle segment was frozen immediately in isopentane, pre-cooled in liquid nitrogen and stored in a freezer at −80°C (Forma Scientific, Marietta, Ohio). Histological cross-sections (10 μm) from the middle belly of each gastrocnemius muscle were obtained in cryostat (Micron HE 505, Jena, Germany), stained with Touluidine Blue/1% Borax (TB) and accessed by light microscopy (Axiolab, Carl Zeiss, Jena, Germany). The CSA of 100 randomly chosen fibers from each picture was measured using the Axiovision 3.0.6 SP4 software (Carl Zeiss, Jena, Germany) totalizing 600 muscle fibers per animal. Data relating to CSA is shown in distribution levels.

The frozen distal muscle segment was macerated in liquid nitrogen and mechanically homogenized with bicarbonate ammonia 50 mM and PIC (Cocktail protease inhibitor), until samples were completely homogenized. Samples were then sonicated for 30 minutes and incubated overnight in a refrigerator (4°C). Subsequently, the sample was centrifuged for 30 min at 14,000 × g. The supernatant was removed and assayed by Qubit® and the remaining samples were used in the LC-MS analysis.

Samples were prepared for LC-MS analysis by tryspin digestion. For this procedure, 20uL of 50mM NH4HCO2 (Vetec) and 50 μl of solution RapiGEST™ (Waters, Milford, MA, USA) was added to each sample, and incubated at 80°C for 15 min and subjected to centrifugation for 15 sec. Subsequently, the supernatant was added to 5 μl of 100 mM dithiothreitol (GE Healthcare) and then the sample was stirred and incubated at 60 °C for 30 min. After the incubation period, the samples were left to cool to room temperature and centrifuged for 15 sec. Subsequently, samples were added to 5 μl 300 mM iodoacetamide (GE Healthcare), shaken and incubated for 30 min at room temperature and protected from light. Then, the sample was added to 40 μL of trypsin solution (Promega Corporation, Brazil) in 50 mM NH~4~HCO~2~ (Vetec) at a concentration of 1:1000; and samples were again shaken and incubated at 37°C for 18 h to digestion. After digestion, 20 μl of trifluoroacetic acid (TFA) 5% (Mallinckr) was added, shaken and samples incubated for 37°C for 90 min. Then, they were centrifuged at 14,000 × g, at 6°C for 30 min. The supernatant was transferred to a microcentrifuge tube (1.5ml) and again evaporated in a lyophilize (LIOTOP). Finally, the samples were resuspended in 0.1% formic acid in LC-MS degree water, mixed, centrifuged for 5 min at 14,000 × g and supernatant then removed and used for analysis.

The LC-MS/MS experiments were performed utilizing high-efficiency liquid chromatography, Shimadzu (Kyoto, Japan) linked to a micrOTOF ESI-Q III (Bruker Daltonics, Germany) mass spectrometer and the peptide separation was performed by making use of an XR-ODS C18 column (2.0 mm × 30 mm × 2.2 microns; Kyoto, Japan). The solvents used were LC-MS degree water (A) and acetonitrile (B) in both solvents were added 0.1% formic acid. The method construed was a gradient of 5% B for 5 min; 5--50% B for 50 min; 50--95% B for 10 min; 95% B for 8 min; 95--5% B for 1 min and 5% B for 7 min, adding up to 80 min under a flow of 400 μL.min−1. The LC-ESI-MS/MS analyses were performed under positive linear mode, in the following parameters: spray voltage, 4.5 kV, by using nitrogen (N~2~) as a source of ionization, nebulizer 4.0 Bar, Drygas 8.0, drytemperature 200 °C. Ions were scanned in a range of 300--3000 m/z followed by five MS/MS scans. The fragmentation (MS/MS) raw data, which were generated by the equipment, were analyzed by using Data Analysis software (Bruker Daltonics, Germany), in all ions that were fragmented according to the parameters mentioned above were separated by means of the AutoMs (n) tool; as a result, the spectra were deconvoluted by using the deconvolution tool in order to determine the peptide levels fragmentation. The data were imported into the Biotools software (Bruker Daltonics, Germany) where the searches were conducted by using the MASCOT algorithm (Matrix Science, London, United Kingdom, version 2.3). The database used in this study included the UniProt, SwissProt, (Switzerland, Geneva), and searches focused on the Rattus spp. taxonomy (546, 439 sequences and 194, 445 396 waste). Trypsin was selected as a cleavage enzyme, followed by possible changes: cysteine carbamidomethylation (C\*), as fixed modification, and methionine oxidation (Mox), as variable modification. The masses tolerance for precursor ions (MS) and for fragments of ions (MS/MS) was ± 0.2 Da. The inclusion criteria for identification of the protein was due to the presence of the protein in at least two of triplicates and are present in three of the five animals from trained groups and two of the four animals from control group analyzed with detection of 1 to 2 ion traces of protein and at least one peptide per protein. The protein identifications considered were those for which the peptides score was greater than the minimum score for the 95% confidence level (p \<0.05), which in turn was obtained by matching each peptide to its theoretical fragmentation profile.

Protein quantification was performed in triplicate and calculated by considering the peak area of the ions found. Two ions were extracted by means of an extracted ion chromatogram tool (XICs), which were associated with the identified protein. The area of each ion was calculated by Integrate Only Chromatogram tool (Bruker Daltonics, Germany) and these values were taken into consideration for the intensity calculations and subsequent comparison with the other groups.

Statistical analysis
--------------------

The results are expressed as means ± standard deviation (SD). Shapiro-Wilk tests were applied to check for normality distribution of study variables. A two-way mixed model ANOVA was used to compare the training load differences between RT4 and RT8 groups. For comparison of study variables between groups a one-way ANOVA with Bonferroni post hoc test was used. The power of the sample size was determined using G\*Power version 3.1.3 ([@b3-ijes_10_7_1051]), based on the differences of CSA of the gastrocnemius between groups. Considering the sample size of this study and an alpha error of 0.05, the power (1 -- β) achieved in this research was 1.0 for the CSA variable. For the inter-group comparative analysis of protein abundance levels, only proteins with up-regulation of Student t test p ≥ 0.95 and down-regulation of p ≤ 0.05 were considered, with a delta (Δ) of at least (≥) 0.5-fold change in Log(e) ratio between the treatments. Among these proteins, p-values less than 0.05 were considered significant ([@b13-ijes_10_7_1051]). The SPSS version 20.0 (Somers, NY, USA) software was used.

RESULTS
=======

Pre and post-training body mass was 384.5 ± 42.6 g versus 396.2 ± 36.1 g for CON group, 349.2 ± 32.2 g versus 365.4 ± 36.5 g for RT4 group and 368.8 ± 32.7 g versus 379.0 ± 33.0 g for RT8 group, with no differences between groups (p \> 0.05). Post-training body mass was significantly higher than pre-training for RT4 (p = 0.004) and RT8 (p = 0.009) groups. Post-training gastrocnemius mass was 2.29 ± 0.32 g for CON group, 2.18 ± 0.37 g for RT4 and 2.39 ± 0.43 g for RT8 group (with no differences between groups; p \> 0.05).

Training load volume progression is presented in [figure 1](#f1-ijes_10_7_1051){ref-type="fig"}. RT8 group performed significantly higher (p \< 0.001) training volume than RT4 group during the 8 weeks of training. A significant increase (p \<0.05) occurred in the training volume until week 5 for RT4 and until week 7 for RT8. The training loads of the groups submitted to training are represented in the [Figure 1](#f1-ijes_10_7_1051){ref-type="fig"}.

By using LC-MS/MS analysis, 52 proteins were identified in gastrocnemius muscle ([supplementary table 1](#s1-ijes_10_7_1051){ref-type="supplementary-material"}). Thirty-nine appeared in all groups; 2 in CON and RT8 groups; 1 in RT4 and RT8 group; 4 appeared only in CON group; another 4 in RT4 group; and 2 in only the RT8 group ([Figure 2](#f2-ijes_10_7_1051){ref-type="fig"}).

The ratio of protein abundance levels in the RT4: CON and the ratio of RT8: CON were evaluated. This portion of the analysis aimed to assess the effect of high and low volume RT over non-exercised gastrocnemius muscle proteome (CON). From the 13 proteins altered after RT8 intervention, the concentration of 12 of them were reduced (down-regulation) and only 1 was enhanced (up-regulation; [figure 3](#f3-ijes_10_7_1051){ref-type="fig"}). When the RT4 group was compared to the CON group, no differences were found regarding the ratio of protein abundance.

[Figure 4](#f4-ijes_10_7_1051){ref-type="fig"} presents the CSA of the gastrocnemius muscle after the intervention. The CSA was significantly higher (p \< 0.001) in RT8 group when compared to RT4 and CON groups. RT4 group also had a significantly higher (p \< 0.001) CSA than CON group. However, no differences (p = 0.970) were found between RT4 and RT8 groups when the CSA of the gastrocnemius muscle were normalized by the total body weight.

In this sense, the main objectives of this study were (i) to compare the effects of eight weeks of lower volume and higher volume of RT on gastrocnemius muscle proteome (ii) and to assess the efficacy of two different RT volumes on muscle cross sectional area (CSA) of rats. Proteomic analysis (LC-MS/MS) identified 51 proteins, with 39 in common between groups, two in common between RT8 and CON groups (nucleoside diphosphate kinase B and troponin T, fast skeletal muscle), one in common between RT8 and RT4 (myosin regulatory light chain 2, skeletal muscle isoform), four exclusive in the CON (heat shock cognate 71 protein, heat shock protein beta-1, tripartite motif-containing protein 72, ATP synthase subunit alpha, mitochondrial), one in the RT8 (aspartate aminotransferase, mitochondrial), and four in the RT4 (glycogen phosphorylase, brain form, myosin-4, citrate synthase, mitochondrial and alpha-crystallin B chain). The RT8 group presented a decrease in the abundance of 12 proteins (involved in muscle protein synthesis, carbohydrate metabolism, tricarboxylic acid cycle, anti-oxidant defense, and oxygen transport) and 1 increased (involved with energy transduction) as compared with CON, while there was no difference between RT4 and CON groups ([figure 5](#f5-ijes_10_7_1051){ref-type="fig"}). Moreover, the CSA was higher in RT8 group as compared with RT4 and CON groups. RT4 group presented a higher muscle CSA as compared with CON group. However, no differences were found between RT4 and RT8 groups when the CSA of the gastrocnemius muscle were normalized by the total body weight. Taken together, the results revealed that higher volume of RT induced a disturbance with respect to skeletal muscle proteins. In addition, lower volume RT resulted in similar muscle hypertrophy gains without negative effects on skeletal muscle proteomics. Thus, the initial hypothesis, that a higher RT volume should increase muscle CSA to a greater extent without negative changes in muscle proteomics, was not confirmed.

DISCUSSION
==========

To the author's knowledge, this was the first study to evaluate the effects of eight weeks of low volume RT and high volume on gastrocnemius muscle proteome and muscle cross sectional area (CSA) of rats, and compare with a control group. The key findings were that high volume RT induced a disturbance on skeletal muscle proteins, while lower volume RT resulted in similar gains in skeletal muscle hypertrophy without impairment of skeletal muscle proteins.

It has been proposed that a single bout of strenuous exercise in untrained animals is more stressful when compared to chronic training. Interestingly, different endurance exercise intensity, volume, and type result in distinct muscle proteomic modulations, where isolated bouts of exercise generally result in reduced alteration in protein expression ([@b14-ijes_10_7_1051]), a finding consistent with the results of the present study performed with resistance exercise. Hody et al. ([@b5-ijes_10_7_1051]) investigated the proteomic response from untrained and trained rectus femoral muscle to two acute intense eccentric exercises (composed of three sets of 30 maximal contractions utilizing an isokinetic dynamometer). Large quantities of myosin heavy chain isoforms as well as several other contractile proteins were decreased after both eccentric sessions in trained and untrained subjects, which was demonstrated in the RT8 group of the present study.

A number of meta-analyses have shown a clear dose-response relationship to be present between the volume of resistance training and muscular adaptations, whereby increased volume correlates with greater gains in muscle strength and hypertrophy, at least up to a certain adaptation ceiling ([@b10-ijes_10_7_1051],[@b11-ijes_10_7_1051],[@b18-ijes_10_7_1051],[@b19-ijes_10_7_1051]). Otherwise, excessive training may result in lipid peroxidation in skeletal muscle and underperformance related to overtraining syndrom, which can be characterized by the time needed to re-establish performance following endurance training. For example, Zoppi and Macedo ([@b26-ijes_10_7_1051]) analyzed the behavior of oxidative stress markers in rats that performed an overreaching (OVR) protocol of 8 weeks of endurance training (ET) and 3 weeks of OVR. The study revealed that the OVR protocol induced higher levels of thiobarbituric acid reactive substances, reactive carbonylated derivatives and the stress protein HSP72 compared with the ET only in the soleus muscle. Thus, an elevated activation of the CrP/creatine kinase system and alterations in creatine kinase expression in the higher RT volume (RT8) could be an earlier indicator of oxidative and bioenergetic stress to the cell, which was not observed in the lower RT volume group (RT4).

Heat shock proteins (HSPs) were also identified exclusively in the control (heat shock cognate 71 protein and heat shock protein beta-1) and RT4 (CRYAB) groups. Sedentary behavior is a condition related to a decreased mobilization of the intramyocellular triglycerides, which results in an increased synthesis of toxic fatty-acid-delivered metabolites (the control group had higher body mass when compared with the trained groups). These metabolites then cause an increased production of reactive oxygen and nitrogen species (ROS and RNS), resulting in oxidative/nitrosative stress, mitochondrial dysfunction, and the activation of stress associated transcription factors, such as tripartite motif-containing protein 72 (TRI72, identified exclusively in the control group). TRI72 acts to sense the oxidative environment that occurs with membrane damage, resulting in disulfide bond formation and homooligomerization at the site of injury. Further, oligomerization functions as a nucleation site for recruitment of TRI72-containing vesicles to the injury leading to membrane repair, and HSP is increased as a danger cellular signal and to combat plasma oxidative damage ([@b9-ijes_10_7_1051]). On another hand, the HSP (Alpha-crystallin B chain) identified exclusively in the RT4 group, has been associated with anti-apoptotic properties, preventing cell death and damage caused by the inflammation response itself in response to diseases, such as stroke or infection, and acts in the maintenance of cytoskeletal integrity ([@b24-ijes_10_7_1051]). This HSP was not identified in the sedentary or RT8 groups, demonstrating that the activation of HSPs seems to be different depending on the environmental stimuli, such as RT or sedentary state, which determines a positive or negative cellular effect.

In terms of muscle hypertrophy, the results indicate an increase in CSA for both RT8 and RT4, when gastrocnemius muscle CSA was normalized by the total body weight. Only one protein was common between RT8 and RT4 (myosin regulatory light chain 2, skeletal muscle isoform). Myosin cross-bridges, which contain both the actin-binding surface as well as the ATP pocket, taper to a helical neck connecting the myosin rRLSod region responsible for self-assembly into thick filaments. Two small protein subunits, the essential light chain and regulatory light chain, circumnavigate each helical neck to provide stability. Regulatory light chain phosphorylation has no noticeable effect on actin-activated myosin ATPase activity but changes myosin cross-bridge properties, resulting in modulation of Ca^+2^/troponin-dependent contractions ([@b8-ijes_10_7_1051]). Previous studies indicated that activity-dependent increases in regulatory light chain phosphorylation could enhance concentric force, work and power during submaximal contractions in vivo ([@b22-ijes_10_7_1051]). However, the discussion of these data is not an easy task, as literature has provided little evidence concerning RLC and muscle hypertrophy induced by RT in rats.

Some limitations of the present study should be considered. The tissue collection occurred 5 days after the last RT session, thus sedentary behavior could result in a loss of a number of proteomic adaptions, while we also wanted to avoid an acute effect of the last training session on several proteins (muscle damage) that could last several days. Additional performance tests and also the inclusion of targeted immunoblot analysis of proteins changing in abundance could be employed. Moreover, the only muscle analyzed was the gastrocnemius, limiting the conclusion regarding other muscle types.

Resistance training provides substantial health benefits and is very effective in improving muscle hypertrophy and strength ([@b17-ijes_10_7_1051]). Quantifying the underlying molecular mechanisms responsible for these favorable effects are in their infancy. Proteomics has been successfully applied for the characterization of the skeletal muscle proteome, representing a relevant approach to characterize the molecular networks of exercise-induced changes in skeletal muscle ([@b12-ijes_10_7_1051],[@b13-ijes_10_7_1051]). Previous studies that analyzed the effects of exercise on muscle proteome in rats were performed utilizing treadmill exercise ([@b13-ijes_10_7_1051]), running wheels ([@b2-ijes_10_7_1051]), and swimming ([@b23-ijes_10_7_1051]). To the best of our knowledge, this is the first study to analyze the effects of higher and lower RT volume on gastrocnemius muscle proteome in rats.

To note, utilization of the muscle proteome presents some limitations that should be highlighted. For example, approximately half of the muscle fiber protein content is related to the contractile mechanism and the high volume of these proteins produced considerable difficulties in detecting and quantifying proteins that were less abundant (such as signaling proteins, transcription factors, and mitochondrial proteins) ([@b14-ijes_10_7_1051]). Finally, most studies with RT were acute and conducted with human biopsies, which may limit the comparisons and data interpretation.

The present study provides evidence that eight weeks of higher volume RT in rats modulates numerous biological pathways that may result in different adaptations of skeletal muscle cell induced by chronic training. Nonetheless, the sedentary state of the control group modulates biological pathways associated with cellular stress, demonstrating the importance of exercise for cellular health. Finally, lower volume RT increased gastrocnemius muscle CSA to a similar degree compared with higher volume, without disturbance of important skeletal muscle proteins. The application of higher volume RT should be followed by sufficient recovery periods to avoid excessive cellular stress, which could lead to undesired long-term training results.

Supplementary materials
=======================

###### 

LC-MS/MS results. Identified proteins from gastrocnemius muscle extract.

  PROTEIN NAME                                                  PRIMARY NAME   MASS (Da)   Mascot Score   SEQUENCE                                            GROUP
  ------------------------------------------------------------- -------------- ----------- -------------- --------------------------------------------------- ---------------
  Fructose-bisphosphate aldolase A                              ALDOA_RAT      39,352      38             FSNEEIAMATVTALR                                     CON, RT4, RT8
  Creatine kinase M-type                                        KCRM_RAT       43,045      29             FCVGLQK 2: Carbamidomethyl (C)                      CON, RT4, RT8
  Actin, alpha skeletal muscle                                  ACTS_RAT       42,051      17             IIAPPER                                             CON, RT4, RT8
  Beta-enolase                                                  ENOB_RAT       47,014      27             TLGPALLEK                                           CON, RT4, RT8
  Glyceraldehyde-3-phosphate dehydrogenase                      G3P_RAT        35,828      119            WGDAGAEYVVESTGVFTTMEK                               CON, RT4, RT8
  Glycogen phosphorylase, muscle form                           PYGM_RAT       97,273      29             LPAPDEKI                                            CON, RT4, RT8
  Tropomyosin alpha-1 chain                                     TPM1_RAT       32,681      63             QLEDELVSLQK                                         CON, RT4, RT8
  Serum albumin                                                 ALBU_RAT       68,731      18             LVQEVTDFAK                                          CON, RT4, RT8
  Pyruvate kinase PKM                                           KPYM_RAT       57,818      51             VNLAMNVGK                                           CON, RT4, RT8
  L-lactate dehydrogenase A chain                               LDHA_RAT       36,451      22             LVIITAGAR                                           CON, RT4, RT8
  Phosphoglycerate mutase 2                                     PGAM2_RAT      28,755      38             FLGDEETVR                                           CON, RT4, RT8
  Phosphoglycerate kinase 1                                     PGK1_RAT       44,538      64             AEPAKIDAFR                                          CON, RT4, RT8
  Triosephosphate isomerase                                     TPIS_RAT       26,849      20             FFVGGNWK                                            CON, RT4, RT8
  Carbonic anhydrase 3                                          CAH3_RAT       29,431      18             VVFDDTFDR                                           CON, RT4, RT8
  Adenylate kinase isoenzyme 1                                  KAD1_RAT       21,584      34             ATEPVISFYDKR                                        CON, RT4, RT8
  Phosphoglucomutase-1                                          PGM1_RAT       61,403      8              QQFDLENK                                            CON, RT4, RT8
  Myoglobin                                                     MYG_RAT        17,157      6              YKELGFQG                                            CON, RT4, RT8
  Hemoglobin subunit alpha-1/2                                  HBA_RAT        15,329      47             MFAAFPTTK                                           CON, RT4, RT8
  Glucose-6-phosphate isomerase                                 G6PI_RAT       62,827      3              VKEFGIDPK                                           CON, RT4, RT8
  Sarcoplasmic/endoplasmic reticulum calcium ATPase 1           AT2A1_RAT      109,409     22             NMLFSGTNIAAGK                                       CON, RT4, RT8
  Hemoglobin subunit beta-1                                     HBB1_RAT       15,979      52             VINAFNDGLK                                          CON, RT4, RT8
  Malate dehydrogenase, cytoplasmic                             MDHC_RAT       36,483      55             LGVTADDVK                                           CON, RT4, RT8
  Myosin light chain 1/3, skeletal muscle M isoform             MYL1_RAT       20,680      65             ITLSQVGDVLR                                         CON, RT4, RT8
  Glycerol-3-phosphate dehydrogenase \[NAD(+)\], cytoplasmic    GPDA_RAT       37,453      54             KLTEIINTQHENVK                                      CON, RT4, RT8
  ATP-dependent 6-phosphofructokinase, muscle type              PFKAM_RAT      85,560      48             IGLIQGNR                                            CON, RT4, RT8
  Protein deglycase DJ-1                                        PARK7_RAT      19,974      42             APLVLKD                                             CON, RT4, RT8
  Heat shock cognate 71                                         HSP7C_RAT      70,871      44             TTPSYVAFTDTER                                       CON, RT4, RT8
  ATP synthase subunit beta, mitochondrial                      ATPB_RAT       56,354      74             VLDSGAPIKIPVGPETLGR                                 CON, RT4, RT8
  Aspartate aminotransferase, cytoplasmic                       AATC_RAT       46,429      29             APPSFFAQVPQAPPVLVFK                                 CON, RT4, RT8
  Troponin T, fast skeletal muscle                              TNNT3_RAT      30,75       72             KPLNIDHLSDDKLR                                      CON, RT4, RT8
  Malate dehydrogenase, mitochondrial                           MDHM_RAT       35,684      44             MIAEAIPELK                                          CON, RT4, RT8
  14-3-3 protein gamma                                          1433G_RAT      28,303      24             TAFDDAIAELDTLNEDSYKDSTLIMQLLR                       CON, RT4, RT8
  Superoxide dismutase \[Cu-Zn\]                                SODC_RAT       15,912      44             VISLSGEHSIIGR                                       CON, RT4, RT8
  Myosin regulatory light chain 2, skeletal muscle isoform      MLRS_RAT       15,912      46             GADPEDVITGAFK                                       CON, RT4, RT8
  Elongation factor 1-alpha 1                                   EF1A1_RAT      50,114      29             IGGIGTVPVGR                                         CON, RT4, RT8
  Aconitate hydratase, mitochondrial                            ACON_RAT       85,425      62             IVYGHLDDPANQEIER                                    CON, RT4, RT8
  Heat shock protein beta-1                                     HSPB1_RAT      22,893      28             LFDQAFGVPR                                          CON, RT4, RT8
  Aldose reductase                                              ALDR_RAT       35,797      23             AIGVSNFNPLQIER                                      CON, RT4, RT8
  Galectin-1                                                    LEG1_RAT       14,857      17             SFVLNLGK                                            CON, RT4, RT8
  Troponin I, fast skeletal muscle                              TNNI2_RAT      21,328      22             MSADAMLK                                            CON
  Alpha-crystallin B chain                                      CRYAB_RAT      20,089      5              HFSPEELKVK                                          CON, RT4, RT8
  Citrate synthase, mitochondrial                               CISY_RAT       51,867      22             AALPSHVVTMLDNFPTNLHPMSQLSAAITALNSESNFAR             CON, RT4, RT8
  Isocitrate dehydrogenase \[NADP\], mitochondrial              IDHP_RAT       50,967      35             LNEHFLNTTDFLDTIKSNLDR                               CON, RT4, RT8
  Filamin-C                                                     FLNC_RAT       290,986     23             EAMQQADDWLGVPQVIAPEEIVDPNVDEHSVMTYLSQFPK            CON
  Electron transfer flavoprotein subunit alpha, mitochondrial   ETFA_RAT       34,951      61             TIVAINKDPEAPIFQVADYGIVADLFK                         CON, RT4, RT8
  Cysteine and glycine-rich protein 3                           CSRP3_RAT      20,803      44             SLESTNVTDKDGELYCK 16: Carbamidomethyl (C)           CON, RT4, RT8
  Calsequestrin-1 OS                                            CASQ1_RAT      46,449      57             AYEDAAEEFHPYIPFFATFDSK                              CON, RT4, RT8
  Microtubule-associated protein 4                              MAP4_RAT       110,301     15             LATTVSAPDLK                                         CON, RT4, RT8
  Serotransferrin                                               TRFE_RAT       76,395      28             TVLPADGPR                                           CON
  Heat shock protein beta-6                                     HSPB6_RAT      17,505      15             FGEGLLEAELASLCPAAIAPYYLR 14: Carbamidomethyl (C)    CON, RT4, RT8
  PDZ and LIM domain protein 3                                  PDLI3_RAT      39,106      41             LSGGIDFNQPLVITR                                     CON, RT8
  Tropomyosin beta chain                                        TPM2_RAT       32,837      28             AISEELDNALNDITSL                                    CON, RT4, RT8
  Actin, aortic smooth muscle                                   ACTA_RAT       42,009      33             LDLAGRDLTDYLMK                                      CON, RT4, RT8
  14-3-3 protein epsilon                                        1433E_RAT      29,174      38             AAFDDAIAELDTLSEESYKDSTLIMQLLR                       CON, RT4, RT8
  Creatine kinase S-type, mitochondrial                         KCRS_RAT       47,385      27             LIDDHFLFDKPVSPLLTCAGMAR 18: Carbamidomethyl (C)     CON, RT4, RT8
  Elongation factor 1-alpha 2                                   EF1A2_RAT      50,454      44             VETGILRPGMVVTFAPVNITTEVK                            CON, RT4, RT8
  Desmin                                                        DESM_RAT       53,457      1              LEEEIRHLK                                           CON, RT4, RT8
  Histone H2B type 1                                            H2B1_RAT       13,99       74             AMGIMNSFVNDIFER                                     CON, RT4
  Tripartite motif-containing protein 72                        TRI72_RAT      52,832      37             MFLAALESSLDREAER                                    CON, RT4, RT8
  Four and a half LIM domains protein 1                         FHL1_RAT       31,904      46             AIVAGDQNVEYK                                        CON, RT4, RT8
  Nucleoside diphosphate kinase A                               NDKA_RAT       17,193      23             VMLGETNPADSKPGTIR                                   CON, RT4, RT8
  Myosin-binding protein C, slow-type (Fragment)                MYPC1_RAT      68,737      47             FTITGLPTDAK                                         CON, RT4, RT8
  Myosin-4                                                      MYH4_RAT       222,88      33             LQDLVDKLQTK                                         CON, RT4, RT8
  ATP synthase subunit alpha, mitochondrial                     ATPA_RAT       59,754      30             TGAIVDVPVGDELLGR                                    CON, RT4, RT8
  Myc box-dependent-interacting protein 1                       BIN1_RAT       64,533      38             LVDQALLTMDTYLGQFPDIK                                CON, RT4
  Vimentin                                                      VIME_RAT       53,733      40             ILLAELEQLKGQGK                                      CON
  Peroxiredoxin-1                                               PRDX1_RAT      22,109      38             ATAVMPDGQFK                                         CON, RT8
  Nestin                                                        NEST_RAT       208,797     21             AVGNEQMAVSPPEK 7: Oxidation (M)                     CON
  Acetyl-CoA acetyltransferase, mitochondrial                   THIL_RAT       44,695      49             IAAFADAAVDPIDFPLAPAYAVPK                            CON
  Peroxiredoxin-5, mitochondrial                                PRDX5_RAT      22,179      17             ALNVEPDGTGLTCSLAPNILSQL 13: Carbamidomethyl (C)     CON, RT4, RT8
  Nucleoside diphosphate kinase B                               NDKB_RAT       17,283      25             NIIHGSDSVESAEKEIGLWFKPEELIDYK                       CON, RT4, RT8
  Myosin-binding protein H                                      MYBPH_RAT      52,656      47             VTAVNSAGAGPPAVLDQPVHIQEITEAPK                       CON, RT8
  Phosphatidylethanolamine-binding protein 1                    PEBP1_RAT      20,801      41             VDYGGVTVDELGK                                       CON, RT4
  Glycogen phosphorylase, brain form (Fragment)                 PYGB_RAT       96,174      9              NLAENISR                                            CON, RT4, RT8
  Long-chain specific acyl-CoA dehydrogenase, mitochondrial     ACADL_RAT      47,873      1              ELWEKAGK                                            CON
  Histidine triad nucleotide-binding protein 1                  HINT1_RAT      13,777      27             AQVAQPGGDTIFGK                                      CON
  Glutathione S-transferase Mu 2                                GSTM2_RAT      25,703      62             LGLDFPNLPYLIDGSHK                                   CON, RT4, RT8
  Histone H2A type 1-C                                          H2A1C_RAT      14,077      38             VTIAQGGVLPNIQAVLLPK                                 RT4
  Tubulin beta-5 chain                                          TBB5_RAT       49,671      29             LTTPTYGDLNHLVSATMSGVTTCLR 23: Carbamidomethyl (C)   RT4
  NEUREXIN-2                                                    NRX2A_RAT      185,169     31             ESADTLR                                             RT4
  Meiosis arrest female protein 1                               MARF1_RAT      192,642     15             NAADDKLR                                            RT4, RT8
  Myosin-3                                                      MYH3_RAT       223,858     82             MKGTLEDQIISANPLLEAFGNAK                             RT4, RT8
  Centrosomal protein CEP57L1 1                                 CE57L_RAT      50,274      17             DRSFQPVK                                            RT4
  IQ DOMAIN-CONTAINING PROTEIN G                                IQCG_RAT       48,757      19             QLVDVKR                                             RT4, RT8
  MICAL-like protein 1                                          MILK1_RAT      92,644      16             MAGPRGALLAWCR 12: Carbamidomethyl (C)               RT4
  F-box only protein 43                                         FBX43_RAT      73,228      33             GTPTVGDLVRQPK                                       RT4
  DNA endonuclease RBBP8                                        COM1_RAT       100,705     30             MDVTVIDTK 1: Oxidation (M)                          RT4, CON
  Tubulin alpha-4A chain                                        TBA4A_RAT      49,924      54             AVFVDLEPTVIDEIR                                     RT4, CON
  Alpha-actinin-1                                               ACTN1_RAT      102,96      25             TFTAWCNSHLR 6: Carbamidomethyl (C)                  RT8
  NON-POU DOMAIN-CONTAINING OCTAMER-BINDING PROTEIN             NONO_RAT       54,925      20             GTFPDAR                                             RT8
  Receptor tyrosine-protein kinase erbB-3                       ERBB3_RAT      147,546     38             IPALDPEK                                            CON, RT8
  Heat shock 70                                                 HS71A_RAT      70,185      45             TTPSYVAFTDTER                                       RT8
  HISTONE ACETYLTRANSFERASE                                     KAT7_RAT       70,514      15             ASEDLEK                                             CON, RT8
  Lymphocyte activation gene 3 protein                          LAG3_RAT       57,988      27             QLSAAVTLAVITVTPK                                    RT8
  Endothelial lipase                                            LIPE_RAT       55,924      13             LVSALQTREK                                          RT8
  ATP-binding cassette sub-family B member 6, mitochondrial     ABCB6_RAT      93,305      40             AIQASLAK                                            RT8
  TRIPARTITE MOTIF-CONTAINING PROTEIN 55                        TRI55_RAT      59,98       19             STSLNYK                                             CON
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![Mean ± SD of training load volume progression during the 8 weeks for GT4 and GT8 groups. \* p \< 0,05 for GT4 group.](ijes_10_7_1051f1){#f1-ijes_10_7_1051}

![Venn diagram analysis of identified proteins interplayed in RT8 (blue), CON (red) and RT4 (green) groups. Exclusive proteins are itemized and assigned into a biological process according to Gen Ontologies (GO) annotations.](ijes_10_7_1051f2){#f2-ijes_10_7_1051}

![Histogram of protein abundance levels due to exercise training on gastrocnemius muscle proteome from intergroup analyses utilizing only proteins with up-regulation (p ≥ 0.95) and down-regulation (p ≤ 0.05) with at least (≥) 0.5-fold change. The x-axis represents the Log(e) ratio between the RT8 and CON groups. Reduction in protein abundances are represented in negative scale (white bars) on the left side and the improvement in protein abundance, in positive scale (black bars) on the right side of the y-axis. No proteins with up- or down-regulation were seen in RT4 group.](ijes_10_7_1051f3){#f3-ijes_10_7_1051}

![Histological sections representing the gastrocnemius muscle cross sectional area (CSA) are exemplified by the images at the top. Below in the graphic, Mean ± SD of muscle CSA and CSA normalized by body weight (CSA:BW) for CON, RT4 and RT8 groups. \* p \< 0,05 for CON group; † p \< 0,05 for RT4 group. (10x). Bar: 100 um.](ijes_10_7_1051f4){#f4-ijes_10_7_1051}

![Modulation in gastrocnemius muscle proteome. The main results found in this study are presented in this muscle cell representation. ^\*^proteins found exclusively to RT8 group; ^†^proteins found exclusively to RT4 group; ^+^proteins found exclusively to CON group (↑): increased abundance levels in contrast to the CON, (↓): reduced abundance levels in contrast to the CON. Protein nomenclature: 14-3-3 γ= 14-3-3 protein gamma; 14-3-3 ɛ= 14-3-3 protein épsilon; A-Hydratase= Aconitate hydratase, mitochondrial; AA = Actin, alpha skeletal muscle; AASM = Actin, aortic smooth muscle; AAM= Aspartate aminotransferase, mitochondrial; Adenylate 1 = Adenylate kinase isoenzyme 1; Asp-aminotransferase = Aspartate aminotransferase, cytoplasmic; ATP-dependent= ATP-dependent 6-phosphofructokinase, muscle type; ATP synthase -- M = ATP synthase subunit alpha, mitochondrial; C-synthase = Citrate synthase, mitochondrial; CA-1; Calsequestrin-1; Carbonic 3 = Carbonic anhydrase 3; CK = Creatine kinase M-type; CK-SM= Creatine kinase S-type, mitochondrial; CryAB= Alpha-crystallin B chain; DJ-1 = Protein deglycase DJ-1; EF1alpha = Elongation factor 1-alpha 1; FHL1= Four and a half LIM domains protein 1; Fructose-A = Fructose-bisphosphate aldolase A; G3PD= Glyceraldehyde-3-phosphate dehydrogenase; Glucose 6 =Glucose-6-phosphate isomerase; GP-brain form = Glycogen phosphorylase, brain form; GP muscle form = Glycogen phosphorylase, muscle form; Glycerol 3 = Glycerol-3-phosphate dehydrogenase (NAD(+)), cytoplasmic; Glyceraldehyde-3= Glyceraldehyde-3-phosphate dehydrogenase; Hb alpha ½ = Hemoglobin subunit alpha-1/2; Hb beta 1 = Hemoglobin subunit beta-1; HS71 = Heat shock cognate 71 kDa protein; HSPB1 = Heat shock protein beta-1; L-lactate A = L-lactate dehydrogenase A chain; Malate dehydrogenase = Malate dehydrogenase, cytoplasmic; Malate -- M = Malate dehydrogenase, mitochondrial; MLC1/3= Myosin light chain 1/3, skeletal muscle isoform; MRLC2 = Myosin regulatory light chain 2, skeletal muscle; M4= Myosin-4; NDK-B = Nucleoside diphosphate kinase B; Phospho 1 = Phosphoglycerate kinase 1; Phospho 2 = Phosphoglycerate mutase 2; Pyruvate K = Pyruvate kinase PKM; S/E -- RC ATPase1 = Sarcoplasmic/endoplasmic reticulum calcium ATPase 1; TA1C= Tropomyosin alpha-1 chain; TAC= Tropomyosin alpha-1 chain; TBC = Tropomyosin beta chain; TMCP72; Tripartite motif-containing protein 72; Triosephosphate = Triosephosphate isomerase; TT fast= Troponin T, fast skeletal muscle.](ijes_10_7_1051f5){#f5-ijes_10_7_1051}
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